These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 28292491)

  • 1. Joint Utility Estimators in Substance Use Disorders.
    Wittenberg E; Bray JW; Gebremariam A; Aden B; Nosyk B; Schackman BR
    Value Health; 2017 Mar; 20(3):458-465. PubMed ID: 28292491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring benefits of opioid misuse treatment for economic evaluation: health-related quality of life of opioid-dependent individuals and their spouses as assessed by a sample of the US population.
    Wittenberg E; Bray JW; Aden B; Gebremariam A; Nosyk B; Schackman BR
    Addiction; 2016 Apr; 111(4):675-84. PubMed ID: 26498740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting utility for joint health states: a general framework and a new nonparametric estimator.
    Bo Hu ; Fu AZ
    Med Decis Making; 2010; 30(5):E29-39. PubMed ID: 20643911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilities should not be multiplied: evidence from the preference-based scores in the United States.
    Fu AZ; Kattan MW
    Med Care; 2008 Sep; 46(9):984-90. PubMed ID: 18725854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating Joint Health Condition Utility Values.
    Thompson AJ; Sutton M; Payne K
    Value Health; 2019 Apr; 22(4):482-490. PubMed ID: 30975400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting utility ratings for joint health States from single health States in prostate cancer: empirical testing of 3 alternative theories.
    Dale W; Basu A; Elstein A; Meltzer D
    Med Decis Making; 2008; 28(1):102-12. PubMed ID: 18057188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development of a model for translation of the Neck Disability Index to utility scores for cost-utility analysis in cervical disorders.
    Richardson SS; Berven S
    Spine J; 2012 Jan; 12(1):55-62. PubMed ID: 22209244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating Joint Health State Utility Algorithms Under Partial Information.
    Bray JW; Thornburg BD; Gebreselassie AW; LaButte CA; Barbosa C; Wittenberg E
    Value Health; 2023 May; 26(5):742-749. PubMed ID: 36307281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of methods to handle skew distributed cost variables in the analysis of the resource consumption in schizophrenia treatment.
    Kilian R; Matschinger H; Löeffler W; Roick C; Angermeyer MC
    J Ment Health Policy Econ; 2002 Mar; 5(1):21-31. PubMed ID: 12529567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting utility scores for prostate cancer: mapping the Prostate Cancer Index to the Patient-Oriented Prostate Utility Scale (PORPUS).
    Bremner KE; Mitsakakis N; Wilson L; Krahn MD
    Prostate Cancer Prostatic Dis; 2014 Mar; 17(1):47-56. PubMed ID: 24126796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-utility analysis of duloxetine in osteoarthritis: a US private payer perspective.
    Wielage RC; Bansal M; Andrews JS; Klein RW; Happich M
    Appl Health Econ Health Policy; 2013 Jun; 11(3):219-36. PubMed ID: 23616247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A linear index for predicting joint health-states utilities from single health-states utilities.
    Basu A; Dale W; Elstein A; Meltzer D
    Health Econ; 2009 Apr; 18(4):403-19. PubMed ID: 18773392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three methods tested to model SF-6D health utilities for health states involving comorbidity/co-occurring conditions.
    Hanmer J; Vanness D; Gangnon R; Palta M; Fryback DG
    J Clin Epidemiol; 2010 Mar; 63(3):331-41. PubMed ID: 19896802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of health utility data when some subjects attain the upper bound of 1: are Tobit and CLAD models appropriate?
    Pullenayegum EM; Tarride JE; Xie F; Goeree R; Gerstein HC; O'Reilly D
    Value Health; 2010; 13(4):487-94. PubMed ID: 20230549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of statistical models to predict mental health and substance abuse cost.
    Montez-Rath M; Christiansen CL; Ettner SL; Loveland S; Rosen AK
    BMC Med Res Methodol; 2006 Oct; 6():53. PubMed ID: 17067394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of substance use and psychiatric disorders in a highly select chronic pain population.
    Proctor SL; Estroff TW; Empting LD; Shearer-Williams S; Hoffmann NG
    J Addict Med; 2013; 7(1):17-24. PubMed ID: 23131838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A behavioral economic analysis of the nonmedical use of prescription drugs among young adults.
    Pickover AM; Messina BG; Correia CJ; Garza KB; Murphy JG
    Exp Clin Psychopharmacol; 2016 Feb; 24(1):38-47. PubMed ID: 26502300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of co-occurring mental and substance use disorders on the prevalence of problem gambling in Canada.
    Rush BR; Bassani DG; Urbanoski KA; Castel S
    Addiction; 2008 Nov; 103(11):1847-56. PubMed ID: 19032535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of classic utilities to published pediatric cost-utility studies.
    Finnell SM; Carroll AE; Downs SM
    Acad Pediatr; 2012; 12(3):219-28. PubMed ID: 22075466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.